Latest Transformation News

Infotrust appoints seasoned tech executive Paul Timmins as CEO, signaling a new phase of growth and cash profitability. The company updates its FY26 second-half EBITDA guidance to $2.3 million amid ongoing cyber security investments and cost efficiencies.

ALS Limited reported a 25.8% jump in underlying net profit after tax to AUD 381.2 million for FY26, driven by strong commodity testing demand and margin expansion. The company raised its dividend and advanced major hub lab projects while navigating a post-year-end cyber incident.

Gentrack Group delivered steady revenue with a 12% rise in recurring income but saw EBITDA fall due to project delays and investment. The company announced two acquisitions to bolster AI and energy pricing capabilities alongside a $20 million share buyback plan.

Gratifii Limited has secured $10 million in new capital to acquire Simplicity Loyalty and invest strategically in Marketplacer, aiming to broaden its loyalty and rewards platform across Australia and New Zealand.

Toubani Resources has locked in a binding commitment for a US$73.3 million senior debt facility from Coris Bank to fund its Kobada Gold Mine construction, advancing its financing package amid strong cash reserves.

Worley unveils a medium-term growth strategy through FY30 focused on expanding full project delivery, investing $70 million in AI, and leveraging strategic partnerships amid near-term geopolitical challenges.

ASX has appointed Anthony Attia as its next Managing Director and CEO, bringing nearly 30 years of global exchange experience to guide the company through its ongoing transformation.

ReadCloud announces CEO Andrew Skelton’s departure after three years of operational overhaul and financial turnaround, appointing CFO Luke Murphy as interim CEO amid strong growth momentum.

Anson Resources and POSCO Holdings have sealed a binding deal for a $7.2 million lithium extraction demonstration plant at Green River, advancing the project from concept to operational validation.

Neurizon Therapeutics has gained ethics approval to start a Phase 1 trial of its NUZ-001 oral liquid formulation, aiming to ease treatment for ALS patients with swallowing difficulties.

Healius updates FY26 guidance with modest earnings growth, flags wage cost pressures from Fair Work ruling, and initiates sale process for high-growth Agilex Biolabs.

The Asian Development Bank ramped up its commitments to $29.3 billion in 2025, driving private sector growth, regional cooperation, and climate resilience across Asia and the Pacific.